FREMONT, CA--(Marketwire - November 30, 2007) - Cardima, Inc. (OTCBB: CADM), developer of the REVELATION® Tx, REVELATION® T-Flex ablation microcatheters and INTELLITEMP® Energy Management Device, announces today the appointment of Sung Chun, MD as its Chief Medical Officer. Dr. Chun completed his cardiology training at Stanford University School of Medicine and is a cardiologist specializing in electrophysiology. He went onto become an Assistant Professor and Associate Director of Cardiac Arrhythmia Service at Stanford University Medical Center. He is currently the Director of Cardiac Arrhythmia Services, Palo Alto Medical Foundation. Dr. Chun has participated in many of the important electrophysiology trials. He has also published widely in leading medical journals and made important contributions to research in this field. Dr. Chun has a long association with Cardima having assisted the Company in clinical trials and product design and enhancements.
